J9049 HCPCS code: Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
J9049 is the HCPCS Level II code for injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg. In 2024 Medicare paid an average of $1.26 per service for J9049 across 50,709 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 35 per day on DME suppliers. Medicare volume fell 5% from 2023 to 2024 (53,492 to 50,709 services). In 2024, about 136 clinicians billed Medicare for J9049 for 180 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2023-01-01 |
| Last action effective | 2023-01-01 |
Who bills J9049 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 136 |
| Medicare beneficiaries | 180 |
| States with claims | 4 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9049, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 53,492 | 221 | $4.86 | $3.83 |
| 2024 | 50,709 | 180 | $1.62 | $1.26 |
States with the most J9049 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 33,782 | $1.27 |
| Ohio | 2,804 | $1.19 |
| New York | 2,566 | $1.28 |
| Texas | 1,676 | $1.28 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 35 | Prescribing Information |
| outpatient hospital claims | 35 | Prescribing Information |
| practitioner claims | 35 | Prescribing Information |
What changed for J9049
- 2023-01-01: J9049 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9049?
J9049 is the HCPCS Level II code for injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg. Short descriptor: "Inj, bortezomib, hospira".
How much does Medicare pay for J9049?
In 2024, the average Medicare payment was $1.26 per service (average allowed $1.62).
Does Medicare cover J9049?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9049 can be billed per day?
35 on DME suppliers; 35 on outpatient hospital claims; 35 on practitioner claims (NCCI medically unlikely edits).
Related J90 codes
- J9000 — Injection, doxorubicin hydrochloride, 10 mg
- J9010 — Injection, alemtuzumab, 10 mg
- J9011 — Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 — Injection, aldesleukin, per single use vial
- J9017 — Injection, arsenic trioxide, 1 mg
- J9019 — Injection, asparaginase (erwinaze), 1,000 iu
- J9020 — Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 — Injection, atezolizumab, 10 mg
- J9023 — Injection, avelumab, 10 mg
- J9024 — Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025 — Injection, azacitidine, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9049
- Watch J9049 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9049
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.